TRCT
OKYO

Tower Research Capital (TRC)’s OKYO Pharma OKYO Stock Holding History

Tower Research Capital (TRC)’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-229
Closed – – 6365
2022
Q2 		$0 Buy
+229
New +$515 ﹤0.01% 6402

Other funds holding OKYO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s OKYO Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of OKYO Pharma (OKYO) in Q3 2022, closing a stake of 229 shares.

Tower Research Capital (TRC) first reported a position in OKYO in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 1 fund tracked by Wall St. Rank holds OKYO as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining OKYO Pharma position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 229 OKYO Pharma shares in Q3 2022.
  • Tower Research Capital (TRC) first reported a position in OKYO Pharma in Q2 2022 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s OKYO Pharma position peaked at $0 in Q2 2022.
  • 1 fund tracked by Wall St. Rank held OKYO Pharma as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.